South Korea - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, South Korea Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases decreased by 5.1% year on year. At 903 Cases in 2019, the country was number 51 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. South Korea is overtaken by Democratic Republic of the Congo, which was ranked number 50 with 918 Cases and is followed by Tajikistan at 878 Cases. India ranked the highest with 66,255 Cases in 2019, that is a growth of 13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 903.00 |
| 2018 | 889.00 |
| 2017 | 836.00 |
| 2016 | 885.00 |
| 2015 | 961.00 |
How does South Korea rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 49 |
#49
Moldova
|
924 | 2019 | +0.5 % | -0.0 % | View data | |
| 51 |
#51
South Korea
|
903 | 2019 | +1.6 % | -5.1 % | View data | |
| 53 |
#53
Ethiopia
|
763 | 2019 | +5.0 % | +8.7 % | View data | |